Reneo Pharmaceuticals Inc (RPHM)

$1.68 0.03 (1.82%)

14:25 EDT RPHM Stock Quote Delayed 30 Minutes

RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q4 2023

By InvestorPlace Earnings Mar 28, 2024

RPHM stock results show that Reneo Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 64,154

Day's Range $1.66 - $1.71

52-Week Range $0.98 - $10.98

Dividend & Yield N/A (N/A)

RPHM Stock Predictions, Articles, and Reneo Pharmaceuticals Inc News

From the Web

Reneo stock plunges 84% as company shuts down lead program (NASDAQ:RPHM)

From Seeking Alpha Dec 14, 2023

Reneo Pharmaceuticals (RPHM) stock plunged 84% after the company said it was shutting down its lead drug program following a failed study. Read more here.

William Blair starts Reneo at outperform, cites mitochondrial disorders drug (NASDAQ:RPHM)

From Seeking Alpha Nov 15, 2023

William Blair initiated coverage of Reneo (RPHM) with an outperform rating, citing the potential of its drug candidate for primary mitochondrial myopathies. Read more here.

HC Wainwright starts Reneo at buy, sees possible 2025 launch for lead drug (RPHM)

From Seeking Alpha Aug 28, 2023

HC Wainwright started coverage of Reneo (RPHM) with a buy rating, citing the prospects of its lead drug mavodelpar in the treatment of primary mitochondrial myopathies, or PMM.

Reneo Pharmaceuticals GAAP EPS of -$0.60 in-line (NASDAQ:RPHM)

From Seeking Alpha May 11, 2023

Reneo Pharmaceuticals press release (RPHM): Q1 GAAP EPS of -$0.60 in-line.Raised $68.3 million in gross proceeds from a concurrent public offering and private placement in May 2023

Reneo slumps 15% on pricing $55M offering (NASDAQ:RPHM)

From Seeking Alpha May 4, 2023

Clinical-stage pharmaceutical company, Reneo Pharmaceuticals (RPHM) prices underwritten public offering of ~6.88M shares at a public offering price of $8.00 per share.Aggregate...

JMP Securities Initiates a Buy Rating on Reneo Pharmaceuticals (RPHM)

From TipRanks Sep 19, 2022

In a report released today, Gobind Singh from JMP Securities initiated coverage with a Buy rating on Reneo Pharmaceuticals (RPHM – Research Report) and a pric...

ADVERTISEMENT